2[2]Lackritz EM. Prevention of HIV transmission by blood transfusion in the developing world: achievements andcontinuing challenges. AIDS,1998, 12 (suppl A): 81～86
3[3]Nitita I, et al. Risk of transfusion - associated HIV transmission in Kinshasa, Zaire. AIDS, 1991, 5:437～439
4[4]Senge JN, Naygeie N. Lessens learned on trends in HIV/AIDS sentinel surveillance in Tanzannia. relying on constantly submitted data.12Th World AIDS Conference, Geneva, 1998
5[5]Christopher Anderson. AIDS scandal indicts French government blood test delayed to help French industry decision was made at the highest levels. Nature, 1991, 353:197
6[6]Leitman SF. Clinical implications of positive tests for antibodies to HIV in asymptomatic blood donors. N Engl J of Med, 1989, 321:917～924
7[7]Julian B. Prevalence of HTLV- Ⅲ antibody in American Blood Donors. N Engl J of Med, 1985, 313:384～385
8[8]Sawanpanyalert P. Donation deferral criteria for HIV positivity among blood donors in northern Thailand. Transfusion, 1996, 36: 242～249
9[9]Petersen LR Doll IS, White R, et al. Heterosexnally acquired HIV infected and the United States blood supply: consideration for screening of potential blood donors. Transfusion, 1993, 33:552～357
10[10]Petersen LR, Satten GA, Dodd R, et al. HIV- 1 infected blood donors: epidemiology, laboratory, and donation characteristics.Transfusion, 1991, 31:698～703
